Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Theseus Pharmaceuticals, Inc. to Concentra Biosciences, LLC for between $3.90 and $4.05 in cash is fair to Theseus.
Biopharmaceutical company Theseus Pharmaceuticals, Inc. (THRX) announced Friday it has entered into a definitive merger agreement whereby Concentra Biosciences, LLC will acquire Theseus for a price per share of Theseus common stock of between $3.
By Dean Seal Shares of Theseus Pharmaceuticals rose after the company agreed to be acquired by Concentra Biosciences for $3.90 to $4.05 a share in cash. The.
Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and $4.05 in cash, consisting of a base cash price of $3.90 per share and an addi
/PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws.